IBL HealthCare Limited (PSX: IBLHL)

Market Cap	2.70B
Revenue (ttm)	4.20B
Net Income (ttm)	222.11M
Shares Out	85.67M
EPS (ttm)	2.59
PE Ratio	12.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,518
Open	31.52
Previous Close	31.36
Day's Range	31.50 - 32.18
52-Week Range	26.08 - 43.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 2, 2024

About IBL HealthCare

IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddlers, baby cereals, infant formulas, medical and lifestyle nutrition, and speciality nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also offers renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, such ...

• Industry: Food & Drug Retailing
• Sector: Consumer Non-Cyclicals
• Founded: 1997
• Employees: 311
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: IBLHL

Financial Performance

In 2023, IBL HealthCare's revenue was 4.03 billion, an increase of 10.32% compared to the previous year's 3.65 billion. Earnings were 308.96 million, an increase of 2.02%.